MY184687A - Methods of inhibiting tumor growth by antagonizing il-6 receptor - Google Patents

Methods of inhibiting tumor growth by antagonizing il-6 receptor

Info

Publication number
MY184687A
MY184687A MYPI2017703406A MYPI2017703406A MY184687A MY 184687 A MY184687 A MY 184687A MY PI2017703406 A MYPI2017703406 A MY PI2017703406A MY PI2017703406 A MYPI2017703406 A MY PI2017703406A MY 184687 A MY184687 A MY 184687A
Authority
MY
Malaysia
Prior art keywords
methods
antagonist
tumor growth
antagonizing
receptor
Prior art date
Application number
MYPI2017703406A
Inventor
Li Zhang
Original Assignee
Regeneron Pharma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharma filed Critical Regeneron Pharma
Priority claimed from PCT/US2012/064311 external-priority patent/WO2013071016A2/en
Publication of MY184687A publication Critical patent/MY184687A/en

Links

Landscapes

  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)

Abstract

The present invention provides methods for inhibiting or attenuating tumor growth in a subject by administering an IL-6 antagonist to the subject. In certain embodiments, the methods of the invention are used to inhibit the growth of an anti-VEGF-resistant tumor in a subject. The IL-6 antagonist may be, e.g., an antibody that specifically binds IL-6R. The IL-6 antagonist may be administered in combination with a VEGF antagonist, and/or an EGFR antagonist. The most suitable drawing: Figure 1.
MYPI2017703406A 2012-11-09 2012-11-09 Methods of inhibiting tumor growth by antagonizing il-6 receptor MY184687A (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
PCT/US2012/064311 WO2013071016A2 (en) 2011-11-10 2012-11-09 Methods of inhibiting tumor growth by antagonizing il-6 receptor
US201661557939P 2016-11-10 2016-11-10
US201761609968P 2017-03-13 2017-03-13
US201761613538P 2017-03-21 2017-03-21

Publications (1)

Publication Number Publication Date
MY184687A true MY184687A (en) 2021-04-16

Family

ID=80933133

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI2017703406A MY184687A (en) 2012-11-09 2012-11-09 Methods of inhibiting tumor growth by antagonizing il-6 receptor

Country Status (1)

Country Link
MY (1) MY184687A (en)

Similar Documents

Publication Publication Date Title
MY163953A (en) Methods of inhibiting tumor growth by antagonizing il-6 receptor
AU2018253544A1 (en) Methods for treating or preventing asthma by administering an IL-4R antagonist
MX2021008113A (en) Methods for treating or preventing asthma by administering an il-4r antagonist.
EP4344706A3 (en) Methods for treating or preventing asthma by administering an il-4r antagonist
BR112013021863A2 (en) il-6 receptor antibodies and methods of use
MX2021002406A (en) Methods for treating eosinophilic esophagitis by administering an il-4r inhibitor.
MX2015002873A (en) Methods for treating atopic dermatitis by administering an il-4r antagonist.
MX368068B (en) Methods for treating nasal polyposis by administering an il-4r antagonist.
WO2016044189A8 (en) Methods of treating cancer using pd-1 axis binding antagonists and il-17 binding antagonists
MA39906A (en) Combination therapies for the treatment of cancer
MX2013010444A (en) Overcoming resistance to erbb pathway inhibitors.
MY189089A (en) Methods of treating cancers using pd-1 axis binding antagonists and taxanes
NZ707086A (en) Anti-cd40 antibodies and methods of use
MX343227B (en) Anti-erbb3 antibodies.
MX2013012572A (en) Anti-cd40 antibodies and methods of use.
NZ626610A (en) Antibodies that bind csf1r
WO2016066634A3 (en) Use of ccr5 antagonists alone or in combination therapy for the treatment of cancer
WO2011154139A3 (en) Gene expression markers for predicting response to interleukin-6 receptor-inhibiting monoclonal antibody drug treatment
EA201591825A1 (en) THE ANTAGONISM OF MYOSTATIN IN SUBJECTS - PEOPLE
MX365242B (en) Use of cxcr4 antagonists.
TR201903312T4 (en) Methods to reduce asthma exacerbation rates using benralizumab.
MX2015005928A (en) Methods of treating ovarian cancer with dll4 antagonists.
WO2018102670A3 (en) Method of treating cancer and method of sensitizing cancer cells to the action of chemotherapeutic agents via growth hormone receptor antagonists or knock down
BR112014014824A2 (en) human growth hormone receptor antagonist antibodies and methods of use
MX2018010546A (en) Methods of treating cancers using pd-1 axis binding antagonists and anti-gpc3 antibodies.